Allworth Financial’s Rani Therapeutics RANI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,119
Closed -$2.37K – 5524
2026
Q2
$2.37K Hold
3,119
– – ﹤0.01% 4437
2026
Q1
$2.29K Hold
3,119
– – ﹤0.01% 4309
2025
Q4
$4.21K Hold
3,119
– – ﹤0.01% 3815
2025
Q3
$1.56K Hold
3,119
– – ﹤0.01% 4114
2025
Q2
$1.6K Hold
3,119
– – ﹤0.01% 3801
2025
Q1
$3.49K Hold
3,119
– – ﹤0.01% 2961
2024
Q4
$4.65K Hold
3,119
– – ﹤0.01% 2799
2024
Q3
$6.74K Hold
3,119
– – ﹤0.01% 2437
2024
Q2
$9.6K Hold
3,119
– – ﹤0.01% 2234
2024
Q1
$9.7K Hold
3,119
– – ﹤0.01% 2132
2023
Q4
$10.4K Hold
3,119
– – ﹤0.01% 1968
2023
Q3
$6.78K Sell
3,119
-3
-0.1% -$11 ﹤0.01% 1983
2023
Q2
$12.9K Hold
3,122
– – ﹤0.01% 1779
2023
Q1
$16.1K Buy
3,122
+3
+0.1% +$18 ﹤0.01% 1585
2022
Q4
$18.4K Buy
+3,119
New +$22.8K ﹤0.01% 1403

Other funds holding RANI

Allworth Financial's RANI Position: Q3 2026 in Review

Allworth Financial sold out of Rani Therapeutics (RANI) in Q3 2026, closing a stake of 3,119 shares — an estimated $2.37K sold.

Allworth Financial first reported a position in RANI in Q4 2022 and held it in 15 quarters. The position peaked at $18.4K in Q4 2022. 68 funds tracked by Wall St. Rank hold RANI as of Q3 2026.

  • Allworth Financial reported no remaining Rani Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Allworth Financial sold 3,119 Rani Therapeutics shares in Q3 2026, an estimated $2.37K.
  • Allworth Financial first reported a position in Rani Therapeutics in Q4 2022 and held it in 15 quarters.
  • Allworth Financial's Rani Therapeutics position peaked at $18.4K in Q4 2022.
  • 68 funds tracked by Wall St. Rank held Rani Therapeutics as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.